- Web traffic, glitches slow Obamacare exchanges launch Reuters - 17 minutes ago
Technical glitches and heavy internet traffic slowed Tuesday's launch of new online insurance exchanges at the heart of President Barack Obama's healthcare reform, showcasing the challenge of covering ...
- ADHD Pill Faces High Hurdle in Europe as Stigma Persists @ Bloomberg - 33 minutes ago
The European debut of a pill to treat children with attention deficit hyperactivity disorder faces a major hurdle: convincing people the condition exists.
- 8 stocks up more than 200% year to date: Cramer @ CNBC - 46 minutes ago
They're among the best performers in the Russell 2000 and they all share something in common. Know what it is?
- KKR Dominating Health Care Spending in 2013 @ The Wall Street Journal - 1 hour 10 minutes ago
Kohlberg Kravis Roberts & Co. is dominating the market for health care deals, even as other firms shy away from the sector amid uncertainty in the U.S. market. The New York firm's $1.7 billion acquisition ...
- F.D.A. Bans Three Arsenic Drugs Used in Poultry and Pig Feeds @ New York Times - 1 hour 20 minutes ago
The Food and Drug Administration’s announcement comes after studies revealed chickens had higher-than-normal levels of the compound, which is primarily used to prevent disease and promote animal growth....
- Final Glance: Medical Devices companies Associated Press - 1 hour 32 minutes ago
Shares of some top medical devices companies were mixed at the close of trading: Allergan rose $.32 or .4 percent, to $90.77. Baxter International Inc. fell $.11 or .2 percent, to $65.58. Boston Scientific ...
- Final Glance: Pharmaceuticals companies Associated Press - 1 hour 32 minutes ago
Shares of some top pharmaceuticals companies were mixed at the close of trading: Baxter International Inc. fell $.11 or .2 percent, to $65.58. Bristol-Myers Squibb Co. rose $.96 or 2.1 percent, to $47.24. ...
- Final Glance: Health Care Equipment companies Associated Press - 1 hour 32 minutes ago
Shares of some top health care equipment companies were mixed at the close of trading: Becton, Dickinson & Co. rose $.90 or .9 percent, to $100.92. Covidien rose $.15 or .2 percent, to $61.09. Patterson ...
- Final Glance: Biotechnology companies Associated Press - 1 hour 32 minutes ago
Shares of some top biotechnology companies were mixed at the close of trading: Amgen Inc. rose $2.66 or 2.4 percent, to $114.58. Biogen Idec rose $4.16 or 1.7 percent, to $244.92. Celgene Corp. rose $3.06 ...
- Final Glance: Drug Benefits companies Associated Press - 1 hour 32 minutes ago
Shares of some top drug benefits companies were up at the close of trading: CVSCaremark rose $.79 or 1.4 percent, to $57.54. Express Scripts Holding Co. rose $.83 or 1.3 percent, to $62.63.
- WellCare to Add Healthfirst NJ Zacks - 1 hour 44 minutes ago
WellCare Health Plans, Inc. agreed to acquire some of the assets of Healthfirst Health plan of New Jersey, Inc. (Healthfirst NJ) for an undisclosed amount.
- We want to hear it from you through MarketWatch's Obamacare survey @ MarketWatch - 1 hour 48 minutes ago
MarketWatch seeks your help in assessing the success or failure of Obamacare through our survey.
- Merck (MRK) Restructures, Cuts 8,500 Positions @ TheStreet.com - 1 hour 53 minutes ago
Merck (MRK) has announced it will cut 8500 positions in efforts to restructure the company and reduce costs.
- 4 Healthcare Stock Stories Making a Big Buzz Today @ Wall St. Cheat Sheet - 1 hour 54 minutes ago
Analysis of Top healthcare Business News: 4 Healthcare Stock Stories Making a Big Buzz Today
- [video] Shutdown not huge for biotech: Pro @ CNBC - 1 hour 54 minutes ago
How are biotech companies and the FDA impacted by the government shutdown? Yaron Werber of Citi Investment Research, offers insight.
- Delcath gets special FDA designation for therapy Associated Press - 1 hour 58 minutes ago
Shares of Delcath Systems Inc. jumped in afterhours trading Tuesday after the medical device and drugmaker said it received preferential regulatory status for its experimental treatment for liver cancer. ...
- Merck drug triggers response in 24 pct of lung cancer patients Reuters - 2 hours 5 minutes ago
Early data from a small trial of Merck & Co Inc's experimental immunotherapy cancer drug, known as MK-3475, showed that about a quarter of lung cancer patients responded to the treatment. Data from the ...
- GOP states offer little help on buying insurance Associated Press - 2 hours 15 minutes ago
On the day consumers start perusing newly launched federal online health exchanges, Republican governors who oppose President Barack Obama's insurance overhaul are mostly sitting on their hands. But the ...
- NextGxDx and athenahealth Join Forces Zacks - 2 hours 24 minutes ago
NextGxDx and athenahealth collaborate to improve genetic testing
- Walgreen fiscal 4Q profit soars 86 percent Associated Press - 2 hours 28 minutes ago
- Merck to cut 8,500 more jobs Associated Press - 2 hours 30 minutes ago
- Health sector sits atop S&P 500 on Obamacare's first day @ MarketWatch - 2 hours 34 minutes ago
The first day of Obamacare was good to health-care companies, as virtually all S&P 500 components in the sector were on the plus side when trading ended on Tuesday, and insurance firms made a mark.
- Budget fight a perfect storm of issues roiling US Associated Press - 2 hours 46 minutes ago
- Government powers down; trading blame in capital Associated Press - 2 hours 53 minutes ago
- [$$] Merck Slashes Jobs @ The Wall Street Journal - 3 hours ago
Merck plans to slash its 81,000-strong workforce by 20% over the next two years as part of a broad restructuring of its R&D practices, a move aimed at adapting the century-old pharmaceutical company to ...
- Cigna Announces Service Initiatives Zacks - 3 hours ago
Cigna rolls out initiatives to provide better service to patients.
- H&R Block shares jump after Morgan Stanley upgrade Associated Press - 3 hours ago
Shares of H&R Block Inc. rose Tuesday after a Morgan Stanley analyst recommended that investors buy shares of the biggest U.S. tax preparer, largely because of its plan to capitalize on the new federal ...
- Exchanges Everywhere, Not A Plan To Buy (Online) @ Forbes - 3 hours ago
A woman looks at the HealthCare. gov insurance exchange internet site October 1, 2013 in Washington, DC. US President Barack Obama's Affordable Care Act, or Obamacare as it is commonly called, passed in March 2010, went into effect Tuesday at 8am EST. Heavy Internet traffic and system problems plagued the [...]
- Healthcare Stocks Up as Obamacare Takes Hold Wyatt Investment Research - 3 hours ago
Healthcare stocks didn't tank the way you might have expected on the day the wheels of Obamacare were set in motion.
- Obamacare Is Here: What Can A Dividend Investor Do? @ Seeking Alpha - 3 hours ago
Healthcare has been the hot sector and it's going to get hotter. Once everyone is finished posturing in Washington, they will simply go ahead and do what should have been done at least a week ago: fund ...
- 2 Biotechs Targeting Brain Cancer @ Seeking Alpha - 3 hours ago
(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.) Brain cancers are among the most deadly and hard-to-treat types of cancer in existence. ...
- Myriad Genetics, BioMarin advance PARP collaboration into Phase 3 Theflyonthewall.com - 3 hours ago
Myriad Genetics (MYGN) announced that BioMarin Pharmaceutical (BMRN) will use Myriad's BRACAnalysis test in connection with its pivotal Phase 3 clinical studies for BMN 673. BMN 673 is a novel, orally-active ...
- Walgreen - Cautious In The Short Run, Long-Term Potential Keeps Increasing @ Seeking Alpha - 3 hours ago
Shares of Walgreen ( WAG ) jumped up following the release of the company's fourth quarter results. Investors are enthusiastic about the deals with Alliance Boots and AmerisourceBergen which start to sort ...
- Why October 1, 2013, matters to medical device industry stocks Market Realist - 3 hours ago
On October 1, 2013, the US government shut down. Look for increased volatility and delayed revenues in medical device stocks and exchange-traded funds.
- Top-line Data on Astellas' Isavuconazole Zacks - 4 hours ago
Astellas Pharma announced positive top-line data from a phase III study (SECURE) on its invasive aspergillosis candidate, isavuconazole.
- Merck’s Big Bet on R&D Founders, and 8,500 Job Cuts Ensue @ BusinessWeek - 4 hours ago
CEO Ken Frazier’s commitment to research and development in recent years has failed to pay off
- Biotech: Let's Make A Billion-Dollar Deal, Part 2 @ Seeking Alpha - 4 hours ago
In the biotechnology world time and money is well spent as long as the end game becomes closer at hand. It's been a very productive few months for both Mannkind ( MNKD ) and Peregrine Pharmaceuticals ( ...
- [$$] Merck Revamp Should Lift Stock @ Barrons.com - 4 hours ago
Merck Revamp Should Lift Stock
- Pro offers less obvious Obamacare stock plays @ CNBC - 4 hours ago
It's too late to buy insurers and hospital stocks, but Bespoke Investment Group's Paul Hickey said there are other ways to play the Obamacare launch.
- Why the Health Care Law Scares the G.O.P. @ New York Times - 4 hours ago
The vehemence of the Tea Party aside, Republican efforts to derail the Affordable Care Act aren’t entirely irrational. It’s a threat to their party.
- [$$] Amid Health Law Rollout, Stryker Boss Braces for Profits and Pain @ The Wall Street Journal - 4 hours ago
With a tax on medical-device makers a top issue in the battle over the federal budget, the CEO of Stryker Corp. says the Affordable Care Act may bring new customers, but at a cost.
- FDA Approves Medtronic's Artificial Pancreas Zacks - 5 hours ago
The Medtronic device is designed to suspend insulin delivery in diabetes patients when blood-sugar levels are very low
- Merck’s Immune System-Based Cancer Drug Works in 1 in 4 Patients @ Bloomberg - 5 hours ago
Merck & Co.’s experimental cancer drug that uses the immune system to target tumors triggered a response in about a quarter of lung cancer patients, according to preliminary results of an early study.
- Amgen Suit by Alleged Professional Whistle-Blower Tossed @ Bloomberg - 5 hours ago
Amgen Inc., the world’s largest biotechnology company, won’t have to face a drug-marketing lawsuit brought by a New Jersey doctor whom the U.S. describes as a professional whistle-blower.
- [video] Health care technology stock picks @ CNBC - 5 hours ago
How the government shutdown is hitting the insurers, and where to buy in the medical device space, with Paul Hickey, Bespoke Investment Group.
- [video] Pro offers less-obvious Obamacare stock plays @ CNBC - 5 hours ago
Paul Hickey, Bespoke Investment Group, says it's too late to buy insurers and hospital stocks on the expectation they'll be helped by Obamacare. Instead, he has some stock recommendations he thinks are ...
- Merck to slash annual costs by $2.5 billion, cut 8,500 jobs Reuters - 5 hours ago
- Merck to slash annual costs by $2.5 bln, cut 8,500 jobs Reuters - 5 hours ago
Merck & Co, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, said it will cut annual operating costs by $2.5 billion and eliminate 8,500 jobs, or more than 10 ...
- Federal health exchange launches in Oklahoma Associated Press - 5 hours ago
- Patent-Suit Abuse Targeted as Supreme Court Accepts Case @ Bloomberg - 5 hours ago
The U.S. Supreme Court will hear two appeals that would make it easier for targets of patent suits to collect attorneys’ fees, agreeing to consider steps that some companies say would deter groundless ...





